Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 11, 2014, Pages 1505-1525

  Beukes, Natasha ^a   Levendal, Ruby Ann ^a   Frost, Carminita L ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

Apoptosis; Phytochemicals; Signalling pathways; Unfolded protein response

Indexed keywords

ABSCISIC ACID; ACTIVATING TRANSCRIPTION FACTOR 6; APOPTOSIS SIGNAL REGULATING KINASE 1; ARTEMISININ; CANNABIDIOL; CANNABINOL; CAROTENE; DRONABINOL; FARNESOL; GANODERIOL F; GENIPIN; GERANIOL; KUJIGAMBEROL; LIMONENE; LINALOOL; LYCOPENE; MARRUBIIN; MENTHOL; MITOGEN ACTIVATED PROTEIN KINASE; PARTHENOLIDE; PERILLYL ALCOHOL; PROTEIN KINASE R; SARCODONIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TERPENOID DERIVATIVE; THAPSIGARGIN; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; PLANT EXTRACT; TERPENE;

BRAIN MALARIA; CELL DEATH; CELL SURVIVAL; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISEASE COURSE; DRUG CLASSIFICATION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENDOPLASMIC RETICULUM STRESS; EPILEPSY; HOMEOSTASIS; HUMAN; INFECTION; INFLAMMATORY BOWEL DISEASE; MEDICINAL PLANT; METABOLIC DISORDER; NEOPLASM; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION; ANGIOSPERM; APOPTOSIS; CHEMISTRY; DRUG EFFECTS; ENDOPLASMIC RETICULUM; METABOLISM; UNFOLDED PROTEIN RESPONSE;

ANGIOSPERMS; APOPTOSIS; DIABETES MELLITUS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HUMANS; INFECTION; NEOPLASMS; PLANT EXTRACTS; PLANTS, MEDICINAL; TERPENES; UNFOLDED PROTEIN RESPONSE;

EID: 84915819896     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12267     Document Type: Review

References (212)

1. Paduch R et al. Terpenes: substances useful in human healthcare. Arch Immunol Ther Exp (Warsz) 2007; 5: 315-327.
2. Ukwe CV, Ubaka CM. Hypoglycemic activity of leaves of Acanthus montanus T.Anderson (Acanthaceae) in rats. Int J Diabetes Dev Ctries 2011; 1: 32-36.
3. Ashok Kumar BS et al. Antidiabetic, antihyperlipidemic and antioxidant activities of methanolic extract of Amaranthus viridis Linn in alloxan induced diabetic rats. Exp Toxicol Pathol 2012; 1-2: 75-79.
4. Thakur CP. Emblica officinalis reduces serum, aortic and hepatic cholesterol in rabbits. Experientia 1985; 3: 423-424.
5. Giancarlo S et al. Hypoglycaemic activity of two spices extracts: Rhus coriaria L and Bunium persicum Boiss. Nat Prod Res 2006; 9: 882-886.
6. Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 2000; 1-2: 23-43.
7. Asada R et al. The signalling from endoplasmic reticulumresident bZIP transcription factors involved in diverse cellular physiology. J Biochem 2011; 5: 507-518.
8. Cunard R, Sharma K. The endoplasmic reticulum stress response and diabetic kidney disease. Am J Physiol Renal Physiol 2011; 5: 1054-1061.
9. Lee AH et al. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 2003; 21: 7448-7459.
10. Sriburi R et al. XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J Cell Biol 2004; 1: 35-41.
11. Acosta-Alvear D et al. XBP1 controls diverse cell type- and conditionspecific transcriptional regulatory networks. Mol Cell 2007; 1: 53-66.
12. Oslowski CM, Urano F. The binary switch that controls the life and death decisions of ER stressed β cells. Curr Opin Cell Biol 2011; 2: 207-215.
13. Burke YD et al. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 1997; 2: 151-156.
14. Goto T et al. Various Terpenoids derived from herbal and dietary plants function as PPAR modulators and regulate carbohydrate and lipid metabolism. PPAR Res 2010; doi: 10.1155/2010/483958
15. Laule O et al. Crosstalk between cytosolic and plastidial pathways of isoprenoid biosynthesis in Arabidopsis thaliana. Proc Natl Acad Sci U S A 2003; 11: 6866-6871.
16. Peñuelas J, Munné-Bosch S. Isoprenoids: an evolutionary pool for photoprotection. Trends Plant Sci 2005; 4: 166-169.
17. Withers ST, Keasling JD. Biosynthesis and engineering of isoprenoid small molecules. Appl Microbiol Biotechnol 2007; 5: 980-990.
18. Milborrow BV. The metabolism of abscisic acid. J Exp Bot 1970; 1: 17-29.
19. Bangerth F. Changes in the ratio of cis-trans to trans-trans abscisic acid during ripening of apple fruits. Planta 1982; 3: 199-203.
20. Agarwal S, Rao AV. Tomato lycopene and its role in human health and chronic diseases. Can Med Assoc J 2000; 6: 739-744.
21. Gouranton E et al. Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem 2011; 7: 642-648.
22. Asaduzzaman M et al. Growing carrots hydroponically using perlite substrates. Sci Hortic (Amsterdam) 2013; 159: 113-121.
23. Bisogno T et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 2001; 4: 845-852.
24. Mecha M et al. Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress. Cell Death Dis 2012; 6: e331-e338.
25. Lim MP et al. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. Cell Death Dis 2011; 6: e170.
26. Caffarel MM et al. Cannabinoids: a new hope for breast cancer therapy? Cancer Treat Rev 2012; 7: 911-918.
27. Gallant M et al. Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes. Phytomedicine 2009; 10: 942-949.
28. Ku CM, Lin JY. Anti-inflammatory effects of 27 selected terpenoid compounds tested through modulating Th1/Th2 cytokine secretion profiles using murine primary splenocytes. Food Chem 2013; 2: 1104-1113.
29. Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 2011; 7: 1344-1364.
30. Yamazaki M et al. Genipin suppresses A23187-induced cytotoxicity in Neuro2a cells. Biol Pharm Bull 2009; 6: 1043-1046.
31. Croteau RB et al. Menthol biosynthesis and molecular genetics. Naturwissenschaften 2005; 12: 562-577.
32. Stark MJ et al. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett 1995; 1: 15-21.
33. Kimura KI et al. Kujigamberol, a new dinorlabdane diterpenoid isolated from 85 million years old Kuji amber using a biotechnological assay. Fitoterapia 2012; 5: 907-912.
34. de Oliveira AP et al. Gastroprotective activity of methanol extract and marrubiin obtained from leaves of Marrubium vulgare L. (Lamiaceae). J Pharm Pharmacol 2011; 9: 1230-1237.
35. Mnonopi N et al. The cardioprotective effects of marrubiin, a diterpenoid found in Leonotis leonurus extracts. J Ethnopharmacol 2011; 1: 67-75.
36. Kamo T et al. Anti-inflammatory cyathane diterpenoids from Sarcodon scabrosus. Biosci Biotechnol Biochem 2004; 6: 1362-1365.
37. Masubuti H et al. Establishment of benzodioxazine core structure for sarcodonin class of natural products by X-ray analysis. Org Lett 2013; 9: 2076-2079.
38. Chang UM et al. Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sci 2006; 12: 1129-1139.
39. Anfosso L et al. Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins. Pharmacogenomics J 2006; 4: 269-278.
40. Krishna S et al. Artemisinins: mechanisms of action and potential for resistance. Drug Resist Updat 2004; 4-5: 233-244.
41. Sen R et al. Efficacy of artemisinin in experimental visceral leishmaniasis. Int J Antimicrob Agents 2010; 1: 43-49.
42. Barrero AF et al. New sources and antifungal activity of sesquiterpene lactones. Fitoterapia 2000; 1: 60-64.
43. Butturini E et al. Two naturally occurring terpenes, dehydrocostuslactone and costunolide, decrease intracellular GSH content and inhibit STAT3 activation. PLoS ONE 2011; 5: 15-21.
44. Hung JY et al. Oxidative and endoplasmic reticulum stress signaling are involved in dehydrocostuslactone-mediated apoptosis in human non-small cell lung cancer cells. Lung Cancer 2010; 3: 355-365.
45. Jamalian A et al. Chemical composition and antifungal activity of Matricaria recutita flower essential oil against medically important dermatophytes and soil-borne pathogens. J de Mycol Med 2012; 4: 308-315.
46. Ghantous A et al. Parthenolide: from plant shoots to cancer roots. Drug Discov Today 2013; 18: 894-905.
47. Feher JJ et al. Ryanodine-sensitive, thapsigargin-insensitive calcium uptake in rat ventricle homogenates. Mol Cell Biochem 1998; 1-2: 9-17.
48. Kozutsumi Y et al. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 1988; 6163: 462-464.
49. Dorner AJ et al. Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. Journal of Biological Chemistry 1989; 34: 20602-20607.
50. Harding HP et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003; 3: 619-633.
51. He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ 2006; 3: 393-403.
52. Koumenis C et al. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α. Mol Cell Biol 2002; 21: 7405-7416.
53. Häcker G. The morphology of apoptosis. Cell Tissue Res 2000; 1: 5-17.
54. Doyle KM et al. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J Cell Mol Med 2011; 10: 2025-2039.
55. Xu C et al. Endoplasmic reticulum stress: cell life and death decisions. J Clin Investig 2005; 10: 2656-2664.
56. Lai E et al. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology 2007; 3: 193-201.
57. Yoshida H. ER stress and diseases. Fed Eur Biochem Soc J 2007; 3: 630-658.
58. Wu J, Kaufman RJ. From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ 2006; 3: 374-384.
59. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010; 6: 900-917.
60. Ortsäter H, Sjöholm A. A busy cellendoplasmic reticulum stress in the pancreatic β-cell. Mol Cell Endocrinol 2007; 1-2: 1-5.
61. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004; 4: 381-389.
62. Oyadomari S et al. Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells. Apoptosis 2002; 4: 335-345.
63. Rao RV et al. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004; 4: 372-380.
64. Szegezdi E et al. Mediators of endoplasmic reticulum stress-induced apoptosis. Eur Mol Biol Organ Rep 2006; 9: 880-885.
65. Kitao Y et al. Expression of the endoplasmic reticulum molecular chaperone (ORP150) rescues hippocampal neurons from glutamate toxicity. J Clin Invest 2001; 10: 1439-1450.
66. Lee JW et al. ER stress is implicated in mitochondrial dysfunctioninduced apoptosis of pancreatic beta cells. Mol Cells 2010; 6: 545-549.
67. Schröder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005b; 74: 739-789.
68. Auf G et al. Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma. Proc Natl Acad Sci U S A 2010; 35: 15553-15558.
69. Lin JH et al. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007; 5852: 944-949.
70. Urano F et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000; 5453: 664-666.
71. Bellail AC et al. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 2004; 6: 1046-1069.
72. Bennewith KL et al. The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 2009; 3: 775-784.
73. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003; 6: 677-684.
74. Hetz C, Glimcher LH. Fine-tuning of the unfolded protein response: assembling the IRE1α Interactome. Mol Cell 2009; 5: 551-561.
75. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 7: 519-529.
76. Schröder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res 2005a; 1-2: 29-63.
77. Yoshida H et al. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001; 7: 881-891.
78. Gardner OS et al. Peroxisome proliferator-activated receptor γ- independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress. J Biol Chem 2005; 11: 10109-10118.
79. Harding HP et al. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999; 6716: 271-274.
80. Roussel BD et al. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol 2013; 1: 105-118.
81. Lu PD et al. Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol 2004; 1: 27-33.
82. Ameri K, Harris AL. Activating transcription factor 4. Int J Biochem Cell Biol 2008; 1: 14-21.
83. Ohoka N et al. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. Eur Mol Biol Organ J 2005; 6: 1243-1255.
84. Brush MH et al. Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1α to the endoplasmic reticulum and promotes dephosphorylation of the α subunit of eukaryotic translation initiation factor 2. Mol Cell Biol 2003; 4: 1292-1303.
85. Ma Y, Hendershot LM. Delineation of a negative feedback regulatory loop that controls protein translation during endoplasmic reticulum stress. J Biol Chem 2003; 37: 34864-34873.
86. Morse E et al. TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1. Am J Physiol Renal Physiol 2010; 5: F965-F972.
87. Fawcett TW et al. Complexes containing activating transcription factor (ATF)/cAMP-responsiveelement- binding protein (CREB) interact with the CCAAT/enhancerbinding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J 1999; 1: 135-141.
88. Harding HP et al. Regulated translation initiation controls stressinduced gene expression in mammalian cells. Mol Cell 2000; 5: 1099-1108.
89. Marciniak SJ et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 2004; 24: 3066-3077.
90. Ma Y et al. Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. J Mol Biol 2002; 5: 1351-1365.
91. Selim E et al. Fibrates upregulate TRB3 in lymphocytes independent of PPARα by augmenting CCAAT/enhancer-binding proteinβ (C/EBPβ) expression. Mol Immunol 2007; 6: 1218-1229.
92. Southwood CM et al. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 2002; 4: 585-596.
93. Cullinan SB, Diehl JA. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int J Biochem Cell Biol 2006; 3: 317-332.
94. Salazar M et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 2009; 5: 1359-1372.
95. Ye J et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell 2000; 6: 1355-1364.
96. Shen J et al. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of golgi localization signals. Dev Cell 2002; 1: 99-111.
97. Du Z et al. Inhibition of IFN-α signaling by a PKC- and protein tyrosine phosphatase SHP-2- dependent pathway. Proc Natl Acad Sci USA 2005; 29: 10267-10272.
98. Werner ED et al. Proteasomedependent endoplasmic reticulumassociated protein degradation: an unconventional route to a familiar fate. Proc Natl Acad Sci U S A 1996; 24: 13797-13801.
99. Yoshida H et al. A time-dependent phase shift in the mammalian unfolded protein response. Dev Cell 2003; 2: 265-271.
100. Haze K et al. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 1999; 11: 3787-3799.
101. Li M et al. ATF6 as a transcription activator of the endoplasmic reticulum stress element: Thapsigargin stress-induced changes and synergistic interactions with NF-Y and YY1. Mol Cell Biol 2000; 14: 5096-5106.
102. Suzuki H et al. Characteristic properties of genipin as an activator in neuronal nitric oxide synthase. J Health Sci 2007; 6: 730-733.
103. Yamazaki M, Chiba K. Neurotrophic effects of genipin on Neuro2a cells. J Health Sci 2005; 6: 687-692.
104. Yamazaki M et al. Differences in neuritogenic response to nitric oxide in PC12 and PC12h cells. Neurosci Lett 2006; 2-3: 222-225.
105. Yamazaki M et al. Neuro2a cell death induced by 6-hydroxydopamine is attenuated by genipin. J Health Sci 2008; 6: 638-644.
106. Yamazaki M. Chibaa K. Expression of functional nitric oxide synthase for neuritogenesis in PC12h cells. J Health Sci 2006; 6: 769-773.
107. Yamazaki M et al. Prevention of the neurotoxicity of the amyloid β protein by genipin. Biol Pharm Bull 2001; 12: 1454-1455.
108. Ohkubo T et al. Detection of genipin/geniposide-target molecules by a geniposide overlay method using anti-geniposide antibody. J Health Sc 2004; 2: 193-196.
109. García-Piñeres AJ et al. Cysteine 38 in p65/NF-κB Plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 2001; 43: 39713-39720.
110. Brüne B et al. Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998; 3: 261-272.
111. He L et al. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 1997; 5: 668-674.
112. Mo H, Elson CE. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isopreonoids. J Nutr 1999; 4: 804-813.
113. Roullet JB et al. Farnesol inhibits L-type Ca 2+ channels in vascular smooth muscle cells. J Biol Chem 1997; 51: 32240-32246.
114. Yu SG et al. Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. J Nutr 1995; 11: 2763-2767.
115. Pahl HL, Baeuerle PA. The ER overload response: activation of NF-κB. Trends Biochem Sci 1997; 2: 63-67.
116. Qu L et al. Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3β. Genes Dev 2004; 3: 261-277.
117. Chawta A et al. Nuclear receptors and lipid physiology: opening the x-files. Science 2001; 5548: 1866-1870.
118. Lazar MA. East meetsWest: an herbal tea finds a receptor. J Clin Invest 2004; 1: 23-25.
119. Dey A et al. Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways. Nat Rev Drug Discov 2008; 12: 1031-1040.
120. Teixeira-Clerc F et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 2006; 6: 671-676.
121. Carracedo A et al. The stressregulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell 2006a; 4: 301-312.
122. Carracedo A et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 2006b; 13: 6748-6755.
123. Mechoulam R et al. Cannabidiol - recent advances. Chem Biodivers 2007; 8: 1678-1692.
124. Eckstein-Ludwig U et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003; 6951: 957-961.
125. Denmeade SR, Isaacs JT. The SERCA pump as a therapeutic target: making a 'smart bomb' for prostate cancer. Cancer Biol Ther 2005; 1: 14-22.
126. Ghantous A et al. What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today 2010; 15-16: 668-678.
127. Cunha DA et al. Initiation and execution of lipotoxic ER stress in pancreatic β-cells. J Cell Sci 2008; 14: 2308-2318.
128. Gurzov EN et al. Signaling by IL-1β + IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ 2009; 11: 1539-1550.
129. Dong M et al. Anti-proliferative and apoptosis-inducible activity of Sarcodonin G from Sarcodon scabrosus in HeLa cells. Int J Oncol 2009; 1: 201-207.
130. Rosa MDSS et al. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob Agents Chemother 2003; 6: 1895-1901.
131. Elson CE et al. Impact of lemongrass oil, an essential oil, on serum cholesterol. Lipids 1989; 8: 677-679.
132. Fitch ME et al. Microbiological screening of mevalonate-suppressive minor plant constituents. J Agric Food Chem 1989; 3: 687-691.
133. Lehmann JM et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferatoractivated receptor γ (PPARγ). J Biol Chem 1995; 22: 12953-12956.
134. Shoff SM et al. Concentrationdependent increase in murine P388 and B16 population doubling time by the acyclic monoterpene geraniol. Cancer Res 1991; 1: 37-42.
135. Takahashi N et al. Dual action of isoprenols from herbal medicines on both PPARγ and PPARα in 3T3-L1 adipocytes and HepG2 hepatocytes. Fed Eur Biochem Soc Lett 2002; 2-3: 315-322.
136. Adany I et al. Differences in sensitivity to farnesol toxicity between neoplastically- and non-neoplastically-derived cells in culture. Cancer Lett 1994; 2: 175-179.
137. Forman BM et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995; 5: 687-693.
138. Haug JS et al. Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: effect of phosphatidylcholine. Biochim Biophys Acta 1994; 1: 133-140.
139. Voziyan PA et al. Mechanism of farnesol cytotoxicity: further evidence for the role of PKC-dependent signal transduction in farnesolinduced apoptotic cell death. Biochem Biophys Res Commun 1995; 2: 479-486.
140. Clegg RJ et al. Inhibition of hepatic cholesterol synthesis and S-3- hydroxy-3-methylglutaryl-CoA reductase by mono and bicyclic monoterpenes administered in vivo. Biochem Pharmacol 1980; 15: 2125-2127.
141. Clegg RJ et al. The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase in vivo in the rat. J Biol Chem 1982; 5: 2294-2299.
142. Qureshi AA et al. Inhibition of hepatic mevalonate biosynthesis by the monoterpene, d-limonene. J Agric Food Chem 1988; 6: 1220-1224.
143. Santos SRL et al. Structure-activity relationships of larvicidal monoterpenes and derivatives against Aedes aegypti Linn. Chemosphere 2011; 1: 150-153.
144. Samarasekera R et al. Insecticidal activity of menthol derivatives against mosquitoes. Pest Manag Sci 2008; 3: 290-295.
145. Haag JD, Gould MN. Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother Pharmacol 1994; 6: 477-483.
146. Mills JJ et al. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 1995; 5: 979-983.
147. Bassaganya-Riera J et al. Abscisic acid regulates inflammation via ligand-binding domain-independent activation of peroxisome proliferator-activated receptor γ. J Biol Chem 2011; 4: 2504-2516.
148. Bruzzone S et al. Abscisic acid is an endogenous stimulator of insulin release from human pancreatic islets with cyclic ADP ribose as second messenger. J Biol Chem 2008; 47: 32188-32197.
149. Guri AJ et al. Dietary abscisic acid ameliorates glucose tolerance and obesity-related inflammation in db/db mice fed high-fat diets. Clin Nutr 2007; 1: 107-116.
150. Burrows TL et al. Validation of overweight children's fruit and vegetable intake using plasma carotenoids. Obesity 2009; 1: 162-168.
151. Kun Y et al. Lycopene: its properties and relationship to human health. Food Rev Int 2006; 4: 309-333.
152. Vivekananthan DP et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: metaanalysis of randomised trials. Lancet 2003; 9374: 2017-2023.
153. Ukil A et al. 18β-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-κB. J Immunol 2005; 2: 1161-1169.
154. Mnonopi N et al. Marrubiin, a constituent of Leonotis leonurus, alleviates diabetic symptoms. Phytomedicine 2012; 6: 488-493.
155. Kee NLA et al. Antithrombotic/ anticoagulant and anticancer activities of selected medicinal plants from South Africa. Afr J Biotechnol 2008; 3: 217-223.
156. Wolcott CD, Rallison ML. Infancyonset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr 1972; 2: 292-297.
157. Oyadomari S et al. Nitric oxideinduced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci U S A 2001; 19: 10845-10850.
158. Hartman MG et al. Role for activating transcription factor 3 in stressinduced β-cell apoptosis. Mol Cell Biol 2004; 13: 5721-5732.
159. Butler AE et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 1: 102-110.
160. Ramadan JW et al. The central role of calcium in the effects of cytokines on beta-cell function: Implications for type 1 and type 2 diabetes. Cell Calcium 2011; 6: 481-490.
161. Lipson KL et al. Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulumresident protein kinase IRE1. Cell Metab 2006; 3: 245-254.
162. Kharroubi I et al. Free fatty acids and cytokines induce pancreatic β-cell apoptosis by different mechanisms: role of nuclear factor-κB and endoplasmic reticulum stress. Endocrinology 2004; 11: 5087-5096.
163. Delépine M et al. EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000; 4: 406-409.
164. Harding HP et al. Diabetes mellitus and exocrine pancreatic dysfunction in Perk-/- mice reveals a role for translational control in secretory cell survival. Mol Cell 2001; 6: 1153-1163.
165. Fonseca SG et al. Endoplasmic reticulum stress in β-cells and development of diabetes. Curr Opin Pharmacol 2009; 6: 763-770.
166. Vinik AI et al. Platelet dysfunction in type 2 diabetes. Diabetes Care 2001; 8: 1476-1485.
167. Coetzee C et al. Anticoagulant effects of a Cannabis extract in an obese rat model. Phytomedicine 2007; 5: 333-337.
168. Levendal RA et al. Cannabis exposure associated with weight reduction and β-cell protection in an obese rat model. Phytomedicine 2012; 7: 575-582.
169. Borradaile NM et al. A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol Biol Cell 2006; 2: 770-778.
170. Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol 2011; 4: 795-809.
171. Özcan U et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 5695: 457-461.
172. Ozcan L et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 2009; 1: 35-51.
173. Dong F, Ren J. Adiponectin improves cardiomyocyte contractile fnction in db/db diabetic obese mice. Obesity 2009; 2: 262-268.
174. Li J et al. Deficiency of Rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes. Diabetes 2010; 8: 2033-2042.
175. Martínez de Morentin PB et al. Hypothalamic lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 2010; 3: 350-361.
176. Boden G et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008; 9: 2438-2444.
177. Sharma NK et al. Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. JCEM 2008; 11: 4532-4541.
178. Tsutsumi A et al. Caloric restriction decreases ER stress in liver and adipose tissue in ob/ob mice. Biochem Biophys Res Commun 2011; 1: 339-344.
179. Özcan U et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006; 5790: 1137-1140.
180. Zhang CY et al. Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced β cell dysfunction in isolated pancreatic islets. Cell Metab 2006; 6: 417-427.
181. Barmada MM et al. A genome scan in 260 inflammatory bowel diseaseaffected relative pairs. Inflamm Bowel Dis 2004; 1: 15-22.
182. Hampe J et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999; 3: 808-816.
183. Vermeire S et al. Genome wide scan in a flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. Gut 2004; 7: 980-986.
184. Bogaert S et al. Involvement of endoplasmic reticulum stress in inflammatory bowel disease: a different implication for colonic and ileal disease? Public Libr Sci ONE 2011; 6: e25589.
185. Velasco G et al. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 2012; 6: 436-444.
186. Caffarel MM et al. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol Cancer 2010; 9: 196.
187. Blázquez C et al. Cannabinoid receptors as novel targets for the treatment of melanoma. Fed Am Soc Exp Biol J 2006; 14: E2199-E2208.
188. Gardner B et al. Methanandamide increases COX-2 expression and tumor growth in murine lung cancer. FASEB J 2003; 14: 2157-2159.
189. McKallip RJ et al. Δ-9- tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 2005; 6: 3281-3289.
190. Zhu LX et al. Δ-9- tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokinedependent pathway. J Immunol 2000; 1: 373-380.
191. Vara D et al. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ 2011; 7: 1099-1111.
192. Shrivastava A et al. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol Cancer Ther 2011; 7: 1161-1172.
193. Shanmugam MK et al. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer. Cancer Lett 2012; 2: 158-170.
194. Paschen W, Frandsen A. Endoplasmic reticulum dysfunction - a common denominator for cell injury in acute and degenerative diseases of the brain? J Neurochem2001; 4: 719-725.
195. Yamamoto A et al. Endoplasmic reticulum stress and apoptosis signaling in human temporal lobe epilepsy. J Neuropathol Exp Neurol 2006; 3: 217-225.
196. Lindholm D et al. ER stress and neurodegenerative diseases. Cell Death Differ 2006; 3: 385-392.
197. Weng WC et al. Role of glucoseregulated protein 78 in embryonic development and neurological disorders. J Formos Med Assoc 2011; 7: 428-437.
198. Sokka AL et al. Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain. J Neurosci 2007; 4: 901-908.
199. Mercado G et al. An ERcentric view of Parkinson's disease. Trends Mol Med 2013; 3: 165-175.
200. Hetz C et al. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 2009; 19: 2294-2306.
201. Liu GL et al. Inositol-requiring protein 1α signaling pathway is activated in the temporal cortex of patients with mesial temporal lobe epilepsy. Neurol Sci 2013; 35: 357-364.
202. Liu G et al. Involvement of IRE1α signaling in the hippocampus in patients with mesial temporal lobe epilepsy. Brain Res Bull 2011; 1: 94-102.
203. Henshall DC, Simon RP. Epilepsy and apoptosis pathways. J Cereb Blood Flow Metab 2005; 12: 1557-1572.
204. Yu N et al. A meta-analysis of pro-inflammatory cytokines in the plasma of epileptic patients with recent seizure. Neurosci Lett 2012; 1: 110-115.
205. Anand SS, Babu PP. Endoplasmic reticulum stress and neurodegeneration in experimental cerebral malaria. Neurosignals 2013; 21: 99-111.
206. de Souza JB, Riley EM. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect 2002; 3: 291-300.
207. van der Heyde HC et al. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 2006; 11: 503-508.
208. Tardif KD et al. Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response. J Biol Chem 2004; 17: 17158-17164.
209. Wati S et al. Dengue virus infection induces upregulation of GRP78, which acts to chaperone viral antigen production. J Virol 2009; 24: 12871-12880.
210. Yu CY et al. Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J Virol 2006; 23: 11868-11880.
211. Medigeshi GR et al. West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J Virol 2007; 20: 10849-10860.
212. Ambrose RL, Mackenzie JM. West Nile virus differentially modulates the unfolded protein response to facilitate replication and immune evasion. J Virol 2011; 6: 2723-2732.